Harte Hanks (HHS) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
15 May, 2026Executive summary
Revenue for Q1 2026 was $37.3 million, down 10.3% year-over-year, with declines across all segments.
Operating loss increased to $0.8 million from $0.04 million in Q1 2025, driven by lower revenues and reduced restructuring charges.
Net loss widened to $0.6 million, or $0.08 per share, compared to $0.4 million, or $0.05 per share, in the prior year.
Advanced sector-aligned growth strategy, focusing on higher-value services and technology-enabled delivery.
Maintained a strong balance sheet with no outstanding debt and $4.5 million in cash at quarter-end.
Financial highlights
Revenue decreased by $4.3 million year-over-year, primarily due to a $3.3 million drop in Fulfillment & Logistics Services.
EBITDA for Q1 2026 was $0.3 million, down from $1.0 million in Q1 2025; Adjusted EBITDA was $0.7 million, down from $1.8 million.
Operating expenses fell 8.6% to $38.0 million, mainly from lower production/distribution and restructuring costs.
Cash and cash equivalents were $4.5 million at March 31, 2026, with $24.3 million available under the credit facility.
No outstanding debt as of March 31, 2026.
Outlook and guidance
Management believes liquidity is sufficient for the next twelve months, with no substantial doubt about going concern.
Positioned to deliver positive EBITDA throughout 2026, leveraging a strong balance sheet and sector focus.
No dividends were paid or planned; share repurchase authorization of $4.1 million remains available.
Latest events from Harte Hanks
- Q2 2026 saw a net loss of $5.0M and a pending acquisition by Star Equity Holdings.HHS
Q2 2026 - All director nominees, Say on Pay, and auditor ratification proposals were approved by majority vote.HHS
AGM 2026 - Operational improvements, governance enhancements, and key votes position the company for growth.HHS
Proxy filing - Positive EBITDA and improved net results in FY 2025 despite lower revenue and segment declines.HHS
Q4 2025 - Shareholders to vote on board, executive pay, and auditor as company targets growth and innovation.HHS
Proxy Filing - Beneficial ownership update adds Rosenbachs as 26.26% holders for 2025 meeting.HHS
Proxy Filing - Q3 2025 revenue dropped 17% with net loss, but cost controls and new deals support outlook.HHS
Q3 2025 - Q3 revenue up 1.1% YoY; profit metrics declined; Q4 revenue expected to contract.HHS
Q3 2024 - Q2 net loss of $27.8M from pension charge; Sales Services surged, cash strong, no debt.HHS
Q2 2024